Dietz Thomas John Insider Trades

Insider Trading History

Track insider trading activity for Dietz Thomas John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $23.1k 30,000 shares
Last Trade
Oct 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.5k 30,000 shares
$2.45
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $23.1k 30,000 shares
Last Trade
Jan 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.4k 30,000 shares
$2.68
$0.77
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Director
Holding Value $44.6k 20,000 shares
Last Trade
Sep 21, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$293k 131,250 shares
$2.23
$2.23
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $13.5k 17,500 shares
Last Trade
Aug 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.7k 17,500 shares
$2.21
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $135k 175,000 shares
Last Trade
Mar 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.95M 175,000 shares
$34.00
$0.77
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Holding Value $69k 40,000 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.05M 40,000 shares
$51.15
$1.72
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Director
Holding Value $156k 70,000 shares
Last Trade
Feb 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.4k 20,000 shares
$2.07
$2.23
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Director
Holding Value $86.3k 50,000 shares
Last Trade
Jan 23, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.13M 50,000 shares
$42.60
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Director
Holding Value $36.2k 21,000 shares
Last Trade
Dec 22, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$763k 22,500 shares
$33.90
$1.72
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $23.1k 30,000 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.29M 30,000 shares
$143.00
$0.77
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Director
Holding Value $75k 43,500 shares
Last Trade
Mar 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.59M 30,000 shares
$153.00
$1.72
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Director
Holding Value $112k 50,000 shares
Last Trade
Feb 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.8k 20,000 shares
$3.89
$2.23
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $46.2k 60,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.6M 60,000 shares
$194.00
$0.77
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Director
Holding Value $64.7k 37,500 shares
Last Trade
Apr 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$630k 2,500 shares
$252.00
$1.72
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Director
Holding Value $60.4k 35,000 shares
Last Trade
Mar 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.49M 25,000 shares
$299.70
$1.72
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Director
Holding Value $66.9k 30,000 shares
Last Trade
Feb 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$122k 16,000 shares
$7.61
$2.23
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $28.7k 37,300 shares
Last Trade
Jan 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.13M 37,300 shares
$218.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $9.62k 12,500 shares
Last Trade
Aug 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.46M 12,500 shares
$196.50
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Director
Holding Value $9.62k 12,500 shares
Last Trade
Apr 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.11M 12,500 shares
$169.00
$0.77
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals EIGR
Director
Holding Value $51.8k 30,000 shares
Last Trade
Mar 16, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$147k 1,000 shares
$147.30
$1.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up